For readers interested in more governance-focused opportunities and underfollowed quality plays, the next stop is our screener containing 20 high quality undiscovered gems.
Eastman Chemical is a US based specialty materials producer with a US$7.3b market cap that supplies chemicals and advanced materials into a wide range of industrial and consumer end markets in the United States, China, and other regions. A governance reset at a business of this size matters because board and shareholder rules shape how capital allocation and long term strategy decisions are proposed, debated, and approved.
The board moved to bring its rulebook into line with current Delaware law and common market practice after October 16, 2026. Updated special meeting procedures, clearer disclosure demands around proposals, and refined proxy access rules give directors a more predictable framework for handling activist campaigns and ordinary shareholder requests.
The new rules do not rewrite the business story, but they do affect how investors can press the board on execution around circular methanolysis, cost savings and projects like Longview ethylene to propylene. Tighter nomination windows and interview requirements in contested elections may raise the bar for challengers who want to redirect capital away from the current plan.
See how these catalysts shape Eastman Chemical's path to a $77.19 fair value.
The key test comes at the next annual meeting, when the new 120 to 90 day advance notice window for director nominations and other proposals is fully in force. Pay attention to whether any shareholder campaigns adjust their timing or tactics around that 2027 meeting date under the revised bylaws.
Add Eastman Chemical to your Watchlist and get alerts as these catalysts play out.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com